Methods and apparatus for fabricating leads with conductors and related flexible lead configurations

Details for Australian Patent Application No. 2008227102 (hide)

Owner Surgi-Vision, Inc. Boston Scientific Neuromodulation Corporation

Inventors Shifflette, J. Michael; Gore, Brian; Allen, Justin M.; Edelstein, William A.; Piferi, Peter; Karmarkar, Parag V.; Bottomley, Paul A.

Agent Spruson & Ferguson

Pub. Number AU-A-2008227102

PCT Pub. Number WO2008/115383

Priority 60/912,835 19.04.07 US; 60/895,619 19.03.07 US; 60/955,730 14.08.07 US

Filing date 13 March 2008

Wipo publication date 25 September 2008

International Classifications

A61N 1/05 (2006.01) Electrotherapy - for implantation or insertion into the body, e.g. heart electrode

A61N 1/16 (2006.01) Electrotherapy

B29C 33/12 (2006.01) Moulds or cores - with incorporated means for positioning inserts, e.g. labels

B29C 39/18 (2006.01) Particular shaping techniques, e.g. moulding, joining

G01N 3/32 (2006.01) Investigating strength properties of solid materials by application of mechanical stress - by applying repeated or pulsating forces

H01B 7/04 (2006.01) Insulated conductors or cables characterised by their form - Flexible cables, conductors, or cords, e.g. trailing cables

A61N 1/37 (2006.01) Electrotherapy

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/115383 Priority application(s): WO2008/115383

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008227105-Bi-directional signal interface and apparatus using same

2008227100-Pyridazinone derivatives useful as glucan synthase inhibitors